"Betamethasone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
Descriptor ID |
D001623
|
MeSH Number(s) |
D04.210.500.745.432.769.199 D04.210.500.908.093
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Betamethasone".
Below are MeSH descriptors whose meaning is more specific than "Betamethasone".
This graph shows the total number of publications written about "Betamethasone" by people in this website by year, and whether "Betamethasone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2000 | 2 | 0 | 2 |
2001 | 2 | 0 | 2 |
2002 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Betamethasone" by people in Profiles.
-
McElwee ER, Wilkinson K, Crowe R, Newman JC, Alkis M, Wineland R, Finneran MM. Indication Creep of Antenatal Late Preterm Steroids. Am J Perinatol. 2022 08; 39(11):1159-1165.
-
Ryan RM, Paintlia MK, Newton DA, Spyropoulos DD, Kemp M, Jobe AH, Baatz JE. Oxygen and steroids affect the regulatory role of natriuretic peptide receptor-C on surfactant secretion by type II cells. Am J Physiol Lung Cell Mol Physiol. 2022 01 01; 322(1):L13-L22.
-
Kircik LH, Schlesinger TE, Tanghetti E. Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis. J Drugs Dermatol. 2020 Sep 01; 19(9):874-880.
-
Sims EJ, Vermillion ST, Soper DE. Preterm premature rupture of the membranes is associated with a reduction in neonatal respiratory distress syndrome. Am J Obstet Gynecol. 2002 Aug; 187(2):268-72.
-
Vermillion ST, Bland ML, Soper DE. Effectiveness of a rescue dose of antenatal betamethasone after an initial single course. Am J Obstet Gynecol. 2001 Nov; 185(5):1086-9.
-
Vermillion ST, Soper DE, Newman RB. Is betamethasone effective longer than 7 days after treatment? Obstet Gynecol. 2001 Apr; 97(4):491-3.
-
Vermillion ST, Soper DE, Bland ML, Newman RB. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Am J Obstet Gynecol. 2000 Oct; 183(4):925-9.
-
Vermillion ST, Soper DE, Newman RB. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol. 2000 Oct; 183(4):810-4.
-
Vermillion ST, Soper DE, Chasedunn-Roark J. Neonatal sepsis after betamethasone administration to patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 1999 Aug; 181(2):320-7.
-
Van Dorsten JP, Horger EO, Miller MC. Preterm rupture of the membranes: combination therapy. Am J Obstet Gynecol. 1985 Sep 15; 153(2):147-53.